MYD88 and CD79B Mutation Analysis in Primary Pharyngeal Diffuse Large B‐Cell Lymphomas: Expanding the MCD‐Like Subtype From the Sinonasal Region to the Upper Airway

We recently identified a high prevalence of the MCD‐like subtype in primary sinonasal DLBCL, defined by MYD88 L265P and/or CD79B Y196 mutations, which is associated with poor prognosis and preferred relapse sites. In this study, we characterized 56 primary pharyngeal DLBCLs and compared them with 55 sinonasal cases from our prior cohort, assessing mutations by droplet digital PCR and immunophenotype by immunohistochemistry. Pharyngeal and sinonasal DLBCLs exhibited site‐specific heterogeneity, with pharyngeal cases showing lower frequencies of MYD88 L265P (15/56 [26.8%] vs. 29/55 [52.7%], p = 0.007) and CD79B Y196 mutations (15/56 [26.8%] vs. 20/55 [36.4%], p = 0.312), and correspondingly fewer MCD‐like cases (20/56 [35.7%] vs. 32/55 [58.2%], p = 0.023). Nevertheless, MCD‐like pharyngeal cases shared similar features with sinonasal MCD‐like cases, including high tendencies for non‐GCB phenotype (75% vs. 96.9%), inferior prognosis, and specific site relapse (CNS, testis, and/or skin). Across the entire upper airway cohort (n = 111), MCD‐like status consistently correlated with site‐specific relapse and adverse clinical outcomes. These findings support expanding the utility of simplified MCD‐like classification as a practical tool for prognostic prediction, relapse site estimation, and therapeutic guidance in upper airway DLBCL, with potential for broader application to anatomically diverse DLBCL‐NOS cases.

• Publication year

  2025

• Venue

  Pathology international (Print)

• Publication date

  2025-12-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/pin.70071PMID 41410279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B‐cell lymphoma

  2025influential reference
• Ectopic germinal centers in the nasal turbinates contribute to B cell immunity to intranasal viral infection and vaccination

  2025cited by this paper
• Therapy for MYD88 L265P DLBCL.

  2025cited by this paper
• Redefining CNS immune privilege

  2025cited by this paper
• Testicular large B‐cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL

  2024cited by this paper
• Redefining our vision: an updated guide to the ocular immune system

  2024cited by this paper
• Immunological memory diversity in the human upper airway.

  2024cited by this paper
• Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

  2024cited by this paper
• Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment Outcomes

  2024cited by this paper
• Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics

  2024cited by this paper
• Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features

  2024cited by this paper
• A single‐centre, real‐world study of BTK inhibitors for the initial treatment of MYD88mut /CD79Bmut diffuse large B‐cell lymphoma

  2024cited by this paper
• Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy.

  2024cited by this paper
• Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation.

  2024cited by this paper
• High Prevalence of MYD88 and CD79B Mutations in Primary Sinonasal Diffuse Large B-Cell Lymphoma

  2024cited by this paper
• Differences in mutational signature of diffuse large B‐cell lymphomas according to the primary organ

  2023cited by this paper
• Prevalence of IRF4 rearrangement in large B-cell lymphomas of the Waldeyer’s ring in adults

  2023cited by this paper
• Olfactory immunology: the missing piece in airway and CNS defence

  2023cited by this paper
• Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial.

  2023cited by this paper
• Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma

  2023cited by this paper
• Sinonasal B‐cell lymphomas: A nationwide cohort study, with an emphasis on the prognosis and the recurrence pattern of primary diffuse large B‐cell lymphoma

  2022cited by this paper
• Mucosal plasma cells are required to protect the upper airway and brain from infection.

  2022cited by this paper
• Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.

  2021cited by this paper
• The genomic and transcriptional landscape of primary central nervous system lymphoma

  2021cited by this paper
• A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.

  2020cited by this paper
• Impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC.

  2020cited by this paper
• Genomic subtypes may predict the risk of central nervous system recurrence in diffuse large B-cell lymphoma.

  2020cited by this paper
• Genetics and Pathogenesis of Diffuse Large B‐Cell Lymphoma

  2018cited by this paper
• Primary Extranodal Diffuse Large B-Cell Lymphomas Are Enriched for Mutations in MYD88 and CD79B.

  2018cited by this paper
• A Multiprotein Supercomplex Controlling Oncogenic Signaling in Lymphoma

  2018cited by this paper
• The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid

  2018cited by this paper
• Oncogenic mutations and chromosomal aberrations in primary extranodal diffuse large B-cell lymphomas of the thyroid--a study of 21 cases.

  2015cited by this paper
• Testicular defense systems: immune privilege and innate immunity

  2014cited by this paper
• High Sensitivity Detection and Quantitation of DNA Copy Number and Single Nucleotide Variants with Single Color Droplet Digital PCR

  2014cited by this paper
• Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study.

  2012cited by this paper
• BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathway

  2012cited by this paper
• Oncogenically active MYD88 mutations in human lymphoma

  2011cited by this paper
• Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

  2010cited by this paper
• Diffuse large B‐cell lymphoma

  2009cited by this paper
• Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.

  2005cited by this paper
• Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

  2004cited by this paper
• Lymphoid Lesions of the Head and Neck: A Model of Lymphocyte Homing and Lymphomagenesis

  2002cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• Immunology of the tonsils.

  1998cited by this paper

• No citing papers are available for this paper.